These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28515369)

  • 1. Effect of Reverse Vessel Remodeling on Regression of Coronary Atherosclerosis in Patients Treated With Aggressive Lipid- and Blood Pressure-Lowering Therapy　- Insight From MILLION Study.
    Gamou T; Sakata K; Tada H; Konno T; Hayashi K; Ino H; Yamagishi M; Kawashiri MA;
    Circ J; 2017 Sep; 81(10):1490-1495. PubMed ID: 28515369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study.
    Kawashiri MA; Sakata K; Hayashi K; Gamou T; Kanaya H; Miwa K; Ueda K; Higashikata T; Mizuno S; Michishita I; Namura M; Nitta Y; Katsuda S; Okeie K; Hirase H; Tada H; Uchiyama K; Konno T; Ino H; Nagase K; Yamagishi M;
    Heart Vessels; 2017 May; 32(5):539-548. PubMed ID: 27798731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
    Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lavoie MA; LeMay M; Cohen E; Levesque S; Keller PF; Heinonen T; Guertin MC
    Am J Cardiol; 2006 Jul; 98(1):23-7. PubMed ID: 16784914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipid-lowering therapy on coronary artery remodeling.
    Schartl M; Bocksch W; Fateh-Moghadam S
    Coron Artery Dis; 2004 Feb; 15(1):45-51. PubMed ID: 15201620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
    Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
    J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.
    Hou J; Xing L; Jia H; Vergallo R; Soeda T; Minami Y; Hu S; Yang S; Zhang S; Lee H; Yu B; Jang IK
    Am J Cardiol; 2016 Mar; 117(5):800-6. PubMed ID: 26778524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
    Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
    J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive remodeling at 3 year follow up is associated with plaque-free coronary wall segment at baseline: a serial IVUS study.
    Wentzel JJ; Gijsen FJ; van der Giessen R; Rodriguez-Granillo G; Schuurbiers JC; Regar E; de Feyter PJ; van der Steen AF
    Atherosclerosis; 2014 Sep; 236(1):82-90. PubMed ID: 25016362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update.
    Hartmann M; Huisman J; Böse D; Jensen LO; Schoenhagen P; Mintz GS; Erbel R; von Birgelen C
    Eur J Echocardiogr; 2011 Apr; 12(4):313-21. PubMed ID: 21421584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Baseline High-Sensitive C-Reactive Protein is Associated with Coronary Atherosclerosis Regression: Insights from the MILLION Study.
    Sakata K; Gamou T; Tada H; Hayashi K; Ino H; Yamagishi M; ;
    J Atheroscler Thromb; 2019 May; 26(5):442-451. PubMed ID: 30249940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.
    Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Hibi K; Sozu T; Terashima M; Michishita I;
    Coron Artery Dis; 2013 Sep; 24(6):481-6. PubMed ID: 23751736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.
    Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease.
    Hung OY; Molony D; Corban MT; Rasoul-Arzrumly E; Maynard C; Eshtehardi P; Dhawan S; Timmins LH; Piccinelli M; Ahn SG; Gogas BD; McDaniel MC; Quyyumi AA; Giddens DP; Samady H
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
    Am J Cardiol; 2012 May; 109(9):1247-53. PubMed ID: 22325089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Crowe T; Kapadia S; Nissen SE
    Am Heart J; 2006 Sep; 152(3):544-50. PubMed ID: 16923429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular Ultrasound Studies of Plaque Progression and Regression: Impact of Lipid-Modifying Therapies.
    Shishikura D; Honda S; Andrews J; Nicholls SJ
    Cardiol Clin; 2018 May; 36(2):329-334. PubMed ID: 29609762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.